(CercleFinance.com) – AstraZeneca announces the appointment of Anne-Laure Dreno as President France from July 1, thus succeeding Olivier Nataf in a context where the group aims to launch 15 new drugs in the world by 2030.
For 17 years with the British healthcare group, Anne-Laure Dreno has held various key management positions in strategy, sales and marketing, at global and regional level – particularly in emerging countries.
She has worked across all of AstraZeneca’s therapeutic areas, giving it solid expertise across its entire therapy portfolio, and held the position of President for Belgium and Luxembourg.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
